Medicare drug plans can now cover Zepbound
Tehnologie
In This Story LLY +1.91% NVO +2.42% El Lilly’s blockbuster weight-loss drug Zepbound is now eligible for Medicare coverage. The news could significantly expand access to the popular, yet costly treatment. Suggested Reading After Nvidia CEO's quantum computing forecast, strategist says 'good luck' to investors Nvidia's dominance in AI will continue, but be cautious with quantum computing stocks, strategist says Bitcoin tumbles to less than $100,000 as a strong U.S. dollar hits crypto Nvidia's
din zilele anterioare